Lilly Said to Near Deal for Psychedelic Drugmaker AtaiBeckley
Eli Lilly is reportedly nearing an acquisition of the psychedelic drugmaker AtaiBeckley, triggering significant movement in the company's share price.
Velocity timeline
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
The brief
Eli Lilly is in discussions to acquire AtaiBeckley, a company focused on the development of psychedelic drugs. Following reports of these negotiations, AtaiBeckley shares experienced substantial growth in after-hours trading.
Coverage from Bloomberg News, Reuters, TradingView, Seeking Alpha, and Yahoo Finance highlights the market reaction, noting significant increases in stock value. Analysts and financial reports have identified the company as a notable stock under $10.
Future developments depend on whether the reported buyout discussions result in a finalized agreement. Coverage does not yet specify the terms of any potential deal or the timeline for a formal announcement.
Synthesized by Newsylist from the headlines below under a strict no-invention contract. ✓ fact-checked: all claims supported by sources Updated just now.
Quick answers
What is driving the movement in AtaiBeckley stock?
The increase in share price is linked to reports regarding potential buyout discussions with Eli Lilly.
Has a deal between Eli Lilly and AtaiBeckley been finalized?
No. Coverage indicates that Eli Lilly is currently nearing a deal, but reports do not confirm a final agreement.
How much has AtaiBeckley's stock risen?
Market reports indicate stock increases ranging between 59% and 66% during after-hours trading.
Coverage (6)
- This Psychedelic Pharma Stock Is Soaring 50% on Report of Eli Lilly Takeover Talks Barron's · 2h ago
- Why Is ATAI Stock Soaring 59% After-Hours? TradingView · 2h ago
- Psychedelic drugmaker AtaiBeckley shares soar 66% on Eli Lilly buyout talks (LLY:NYSE) Seeking Alpha · 2h ago
- Here Is Why AtaiBeckley (ATAI) Is One Of The 10 Best Stocks Under $10 That Could Triple Yahoo Finance · 2h ago
- Eli Lilly nears deal to buy psychedelic drugmaker AtaiBeckley, Bloomberg News reports Reuters · 2h ago
- Lilly Said to Near Deal for Psychedelic Drugmaker AtaiBeckley Bloomberg.com · 2h ago broke it first
People, places & organizations
Topics
Related trends
Conagra Stock Falls as Guidance Disappoints and the Company Reduces Dividend
Conagra stock is sliding following a dividend cut, a significant impairment charge, and a conservative fiscal outlook for 2027.
Why This Biotech Stock, With Its First FDA Approval, Just Crashed By Double Digits
5 news sources are covering this Business story right now — Newsylist is tracking how fast it spreads.
Stock market today: Dow, S&P 500, Nasdaq futures extend gains ahead of earnings, wholesale inflation data
U.S. stock futures climb as investors weigh cooling wholesale inflation and upcoming quarterly earnings reports.
ASML Raises Outlook, Plans Capacity Hike as AI Boosts Demand
ASML shares climbed following a second-quarter earnings beat and an upward revision of its 2026 financial guidance.
Why Intuitive Surgical And Its Peers Just Took A Tumble
5 news sources are covering this Business story right now — Newsylist is tracking how fast it spreads.
IBM Shares Crash 24% Toward Worst Day Ever—Here’s Why
IBM shares plummeted over 25% in a single day, erasing $69 billion in market value following preannounced earnings results.